← Open Payments lookup

MARK PEDIGO: Open Payments

NPI 1144798570 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,336 in 195 payments from 36 companies in 2025. Trend: 2023 $3,120 · 2024 $2,066 · 2025 $3,336

Food & beverage: $3,336
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$356
AstraZeneca Pharmaceuticals LP15$284
Novo Nordisk Inc17$283
Bayer Healthcare Pharmaceuticals Inc.19$257
ABBVIE INC.19$246
Novartis Pharmaceuticals Corporation8$199
Lundbeck LLC13$181
Lilly USA, LLC11$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$167
GlaxoSmithKline, LLC.6$123

Products named: REXULTI, Kerendia, LEQVIO, Ozempic, FARXIGA, CAPLYTA, VRAYLAR, MOUNJARO.

Industry payments across TX — which companies pay providers there.